|
Volumn 177, Issue , 2008, Pages 131-136
|
Targeted therapy of the epidermal growth factor receptor in the treatment of pancreatic cancer.
a
a
MERCK KGAA
(Germany)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBODY;
EPIDERMAL GROWTH FACTOR RECEPTOR;
ANIMAL;
CLINICAL TRIAL;
DRUG ANTAGONISM;
ENZYMOLOGY;
HUMAN;
IMMUNOLOGY;
IMMUNOTHERAPY;
METABOLISM;
PANCREAS TUMOR;
REVIEW;
ANIMALS;
ANTIBODIES;
CLINICAL TRIALS AS TOPIC;
HUMANS;
IMMUNOTHERAPY;
PANCREATIC NEOPLASMS;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
MLCS;
MLOWN;
|
EID: 38449089807
PISSN: 00800015
EISSN: None
Source Type: Journal
DOI: 10.1007/978-3-540-71279-4_15 Document Type: Review |
Times cited : (6)
|
References (28)
|